Joan Dahmer studies various aspects of infectious diseases and patient care. One of her key areas is developing rapid testing techniques for viral infections, such as COVID-19, measles, and Zika, utilizing saliva and portable sample processing methods. She also explores new antimicrobial agents derived from plants to address antibiotic resistance and has worked on improving the safety of parenteral nutrition for patients who cannot eat by mouth. Her research aims to enhance public health responses and improve patient outcomes through more efficient diagnostic and treatment options.
Key findings
Developed a saliva-based test for viral diseases with 100% accuracy for COVID-19 detection and 91.7% specificity for measuring immunity levels.
Created a digital microfluidic method that reduces sample volume to 100 microliters while maintaining reliable protein detection in small samples.
In a study in the Democratic Republic of the Congo, 54% of suspected measles cases tested positive for rubella, highlighting the need for vaccination.
Verified that a portable testing system for Zika virus had perfect sensitivity in detecting Zika RNA but 75% specificity for identifying non-Zika samples.
Identified new alkaloids from the bark of Scutia buxifolia with antibacterial properties comparable to existing antibiotics.
Frequently asked questions
Does Dr. Dahmer study viral infections?
Yes, she develops rapid testing methods for viral infections, including COVID-19, measles, and Zika.
What treatments has Dr. Dahmer researched?
She has researched new antimicrobial treatments derived from plants and improved methods for parenteral nutrition.
Is Dr. Dahmer's work relevant to patients needing nutrition support?
Absolutely, her research aims to enhance the safety and effectiveness of parenteral nutrition for those who cannot eat.
How does Dr. Dahmer's work help with antibiotic resistance?
She studies natural compounds from plants that can fight bacteria, offering potential new treatments for infections resistant to current antibiotics.
Can Dr. Dahmer's testing methods be used in remote areas?
Yes, her portable testing systems are designed for rapid use in areas with limited resources, improving outbreak control.
Publications in plain English
Quality improvement for parenteral nutrition in hospital: Applying a gap analysis to an electronic health record to review parenteral nutrition processing.
2025
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
Kulyk A, Dahmer J, Gramlich L
Plain English This study focused on improving the safety of parenteral nutrition (PN), a special type of feeding given to patients who can't eat by mouth. Researchers analyzed how well their electronic health record (EHR) system, Epic, worked in managing PN processes and found that it currently supports 32 out of 40 safety functions. They identified three key improvements to implement: better communication between equipment and EHR, easier approval of modified orders from pharmacists, and enhanced decision-making tools for doctors.
Who this helps: This benefits patients who require parenteral nutrition and healthcare providers involved in their care.
A digital microfluidic approach to increasing sample volume and reducing bead numbers in single molecule array assays.
2025
Lab on a chip
Salari A, Camacho Valenzuela JG, Le N, Dahmer J, Sklavounos AA +5 more
Plain English This study focused on improving a testing method called Simoa, which is used to detect proteins at very low levels in small samples. Researchers created new techniques to better manipulate tiny magnetic beads required for these tests, allowing them to use just 100 microliters of liquid and as few as 1,000 beads while still achieving accurate results comparable to larger, traditional testing methods. These advancements could make it easier and more efficient to perform sensitive protein tests in small volumes, which is especially important in clinical settings.
Who this helps: Patients needing precise and efficient medical tests.
A combined digital microfluidic test for assessing infection and immunity status for viral disease in saliva.
2025
Lab on a chip
Sathishkumar N, Camacho Valenzuela JG, Le NH, Yong AKC, Rossotti MA +12 more
Plain English This research focused on creating a new test that can quickly assess both infection and immunity to viral diseases using saliva samples. The test successfully identified the presence of the SARS-CoV-2 virus with perfect accuracy (100% sensitivity and specificity) and also measured immunity levels with high accuracy (91.7% specificity for IgG and 90.9% for IgA). This is important because it could lead to better public health responses during outbreaks, helping to detect infections and monitor immunity more effectively.
Who this helps: Patients, public health officials, and healthcare providers.
Alkaloids from the stem barks of Scutia buxifolia Reissek (Rhamnaceae): Structures and antimicrobial evaluation.
2022
Phytochemistry
Dahmer J, Marangon P, Adolpho LO, Reis FL, Maldaner G +4 more
Plain English Researchers studied the chemical compounds found in the bark of the Scutia buxifolia tree and discovered several new alkaloids, which are natural compounds that can have health benefits. They found that one compound, 27-epi-scutianine N, showed strong antibacterial effects similar to the antibiotic chloramphenicol, while other compounds were less effective. This is important because it may lead to new treatments for bacterial infections, especially those that are resistant to current antibiotics.
Who this helps: This helps patients with bacterial infections and doctors seeking new treatment options.
Portable sample processing for molecular assays: application to Zika virus diagnostics.
2022
Lab on a chip
Narahari T, Dahmer J, Sklavounos A, Kim T, Satkauskas M +9 more
Plain English This research focused on developing a portable system to quickly and accurately test for the Zika virus using a new technology called digital microfluidics. The system demonstrated perfect sensitivity, meaning it correctly identified Zika RNA every time, but had a specificity of 75%, meaning it correctly identified non-Zika samples about three-quarters of the time. This technology is important because it allows for rapid testing in remote areas, which can help control outbreaks more effectively.
Who this helps: This helps patients in remote areas and healthcare providers conducting virus testing.
Applying FHIR Genomics for Research - From Sequencing to Database.
2022
AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science
Hernandez S, Fairchild K, Pemberton M, Dahmer J, Zhang W +2 more
Plain English This study focused on improving how genomic data from next-generation sequencing (NGS) is organized and shared. Researchers successfully combined genomic data with established standards, allowing it to be stored and accessed more effectively in a database. By doing this, they expect to boost clinical trial recruitment, improve the quality of genomic testing within institutions, and enhance research collaboration across different health organizations.
Who this helps: This benefits researchers, healthcare institutions, and patients by facilitating better access to genomic information for treatment.
Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo.
2022
PloS one
Knipes AK, Summers A, Sklavounos AA, Lamanna J, de Campos RPS +25 more
Plain English This study looked at a new rapid testing method to detect measles and rubella infections in the Democratic Republic of the Congo, which is facing a high rate of measles cases and has not introduced a rubella vaccine. Out of 157 suspected measles cases tested, 54% had rubella infection while only 13% had measles. The findings showed that vaccinated individuals had a higher rate of measles immunity (87%) compared to unvaccinated individuals (72%) and highlighted the urgent need to add a rubella vaccine to the national immunization program.
Who this helps: Patients, especially children in DRC, will benefit from better vaccination strategies and rapid testing to control outbreaks.
Antibacterial activity of Discaria americana Gillies ex Hook (Rhamnaceae).
2019
Journal of ethnopharmacology
Dahmer J, do Carmo G, Mostardeiro MA, Neto AT, da Silva UF +2 more
Plain English This study looked at the antibacterial properties of a plant called Discaria americana, traditionally used in medicine in parts of South America. The researchers found that extracts from the plant were effective against several harmful bacteria, with the most potent compound, discarine B, showing a strength similar to the antibiotic levofloxacin in fighting the bacteria Enterococcus faecium. This finding supports the traditional use of the plant and suggests it could be a valuable source of new antibacterial agents.
Who this helps: Patients with bacterial infections and healthcare providers looking for alternative treatments.
Root bark of Discaria americana attenuates pain: A pharmacological evidence of interaction with opioidergic system and TRP/ASIC channels.
2018
Journal of ethnopharmacology
Simões RR, Kraus SI, Rosso R, Bridi A, Casoti R +4 more
Plain English This study looked at the root bark of a plant called Discaria americana to see if it could help reduce pain in mice. The researchers found that a specific extract from the plant significantly lowered pain responses caused by different painful stimuli, including chemicals and heat, especially at a dose of 300 mg/kg; pain reduction was linked to its interaction with the body’s opioid system. This is important because it supports the traditional use of this plant in medicine and shows it could be developed into new pain relief treatments.
Who this helps: This helps patients looking for natural pain relief options.
Cyclopeptide alkaloids: stereochemistry and synthesis of the precursors of discarines C and D and myrianthine A.
2013
Journal of natural products
Mostardeiro MA, Ilha V, Dahmer J, Caro MS, Dalcol II +2 more
Plain English This study focused on three specific compounds called cyclopeptide alkaloids, which were sourced from the plant Discaria febrifuga. Researchers determined the unique shapes of these compounds and developed a method to synthesize important building blocks for them. They successfully created four variations of a specific amino acid, which is crucial for making synthetic peptides, allowing for more precise control in how these compounds are produced.
Who this helps: This benefits researchers and pharmaceutical companies working on drug development.
Evaluation of an integrated multi-media learning system.
1976
Medical education
Dahmer J, Pietzka B, Walther R
Plain English This study compared two teaching methods for students: the traditional approach using textbooks and personal demonstrations versus a modern multimedia system that includes text, slides, and audio. The results showed that students using the multimedia system scored better in theoretical knowledge, felt more confident, and made fewer mistakes during experiments. Specifically, students using the multimedia system had significantly higher gains in their understanding compared to those using traditional methods.
Who this helps: This benefits students learning complex subjects, especially in fields like science and technology.